Ethical guidelines in pandemic influenza: recommendations of the Ethics Subcommittee of the Advisory Committee of the Director, Centers for Disease Control and Prevention.
Because of the importance of including ethical considerations in planning efforts for pandemic influenza, in February 2005 the Centers for Disease Control and Prevention requested that the Ethics Subcommittee of the Advisory Committee to the Director develop guidance that would serve as a foundation for decision making in preparing for and responding to pandemic influenza. Specifically, the ethics subcommittee was asked to make recommendations regarding ethical considerations relevant to decision making about vaccine and antiviral drug distribution prioritization and development of interventions that would limit individual freedom and create social distancing. The ethics subcommittee identified a number of general ethical considerations including identification of clear goals for pandemic planning, responsibility to maximize preparedness, transparency and public engagement, sound science, commitment to the global community, balancing individual liberty and community interests, diversity in ethical decision making, and commitment to justice. These general ethical considerations are applied to the issues of vaccine and antiviral drug distribution and use of community mitigation interventions.
Kinlaw
Kathy
K
Center for Ethics, Emory University, GA, USA.
Barrett
Drue H
DH
Levine
Robert J
RJ
D000998:Antiviral Agents / Q000600:supply & distribution; D002487:Centers for Disease Control and Prevention, U.S.; D002961:Civil Rights; D003657:Decision Making; D004189:Disaster Planning / Q000458:organization & administration; D004196:Disease Outbreaks / Q000941:ethics*; D017408:Guidelines as Topic; D015276:Health Care Rationing / Q000941:ethics* / Q000458:organization & administration; D006801:Humans; D007252:Influenza Vaccines / Q000600:supply & distribution; D007251:Influenza, Human / Q000453:epidemiology*; D026684:Personal Autonomy; D012935:Social Justice; D014481:United States / Q000453:epidemiology
D000998:Antiviral Agents; D007252:Influenza Vaccines